Pfizer and Arvinas' jointly develop oral treatment for breast cancer

A small molecule oral treatment for breast cancer has been granted fast-track designation by the US Food and Drug Administration (FDA).

Related Keywords

Roger Dansey ,John Houston ,Pfizer ,Targeting Chimera ,Fast Track ,Clinical Development ,Drug Delivery ,Ingredients ,Contract Manufacturing Amp Logistics ,Markets Amp Regulations ,Atient Centricity ,Linical Evolution ,Pis Active Pharmaceutical Ingredients ,Regulations ,Breast Cancer ,Harmacology ,Small Molecule Drugs ,Ther2 ,